Leaflet NOVOTHYRAL 100mcg / 20mcg tablets

Indicated for: hypothyroidism

Route of administration: oral

Substance: levothyroxine + liothyronine (thyroid hormones)

ATC: H03AA03 (Systemic hormonal preparations, excluding sex hormones and insulins | Thyroid preparations | Thyroid hormones)

The combination of levothyroxine and liothyronine is used for the treatment of hypothyroidism, particularly in cases where levothyroxine monotherapy is insufficient. Levothyroxine and liothyronine are synthetic thyroid hormones that replace natural hormones.

The medication is taken orally, usually once daily in the morning on an empty stomach. The dose is adjusted based on blood thyroid hormone levels and the patient's clinical response.

Side effects may include palpitations, anxiety, insomnia, or diarrhea. In rare cases, treatment-induced hyperthyroidism or allergic reactions may occur.

This combination is not recommended for patients with hyperthyroidism, untreated adrenal insufficiency, or hypersensitivity to any of the components.

General data about NOVOTHYRAL 100mcg / 20mcg

Substance: levothyroxine + liothyronine
Date of last drug list: 01-05-2026
Commercial code: W66150001
Concentration: 100mcg / 20mcg
Pharmaceutical form: tablets
Quantity: 100
Product type: original
Price: 39.35 RON
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: MERCK HEALTHCARE KGAA - GERMANIA
Holder: MERCK ROMANIA SRL - ROMANIA
Number: 12015/2019/01
Shelf life: 2 years

Concentrations available for levothyroxine + liothyronine

100mcg+20mcg
100mcg/20mcg

Compensation lists for NOVOTHYRAL 100mcg / 20mcg Merck Sharp & Dohme

C3 - Sublist C - section C3 (children, pregnant women and postpartum women) with 100% discount from the reference price

Price

Copayment

Patient

39.35 RON

0.00 RON